M. Leoz

发表

Evidence of Transmission and Circulation of Deltacron XD Recombinant Severe Acute Respiratory Syndrome Coronavirus 2 in Northwest France

M. Ar Gouilh, J. Plantier, A. Moisan, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

First report of transmission of a highly resistant strain of HIV-1 group O.

L. Meyer, J. Plantier, T. Mourez, 2016, AIDS.

Performance Analysis of Three Commercial Kits Designed for RNA Quantification of HIV-1 Group O Variants

J. Plantier, M. Gueudin, E. Alessandri-Gradt, 2021, Journal of acquired immune deficiency syndromes.

HIV‐1 non‐group M phenotypic susceptibility to integrase strand transfer inhibitors

C. Charpentier, D. Descamps, J. Plantier, 2017, The Journal of antimicrobial chemotherapy.

First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon.

V. Lemée, J. Plantier, F. Simon, 2010, AIDS.

Diagnosis and Monitoring of HIV-1 Group O-Infected Patients in Cameroun

D. Rousset, J. Plantier, F. Simon, 2010, Journal of acquired immune deficiency syndromes.

Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain

G. Learn, F. Kirchhoff, B. Hahn, 2017, Journal of Virology.

Differential utilization of CD4 by transmitted/founder and chronic envelope glycoproteins in a MSM HIV-1 subtype B transmission cluster.

A. Moreau, F. Mammano, Olivia Blake, 2020, AIDS.

A new human immunodeficiency virus derived from gorillas

François Simon, David L Robertson, Jean-Christophe Plantier, 2009, Nature Medicine.

Proceedings of the Frontiers of Retrovirology Conference 2016

R. König, D. Elleder, R. Sachidanandam, 2016, Retrovirology.

Within-Host Microevolution of Pseudomonas aeruginosa Urinary Isolates: A Seven-Patient Longitudinal Genomic and Phenotypic Study

F. Aujoulat, S. le Hello, E. Jumas‐Bilak, 2021, Frontiers in Microbiology.

Performance of the Liaison XL Murex HIV Ab/Ag Test on Clinical Samples Representing Current Epidemic HIV Variants

V. Lemée, J. Plantier, M. Etienne, 2014, Journal of Clinical Microbiology.

Differential Regulation of NF-κB-Mediated Proviral and Antiviral Host Gene Expression by Primate Lentiviral Nef and Vpu Proteins

C. Van Lint, F. Kirchhoff, B. Hahn, 2015, Cell reports.

HEXIM1-Tat chimera inhibits HIV-1 replication

B. Peterlin, F. Huang, K. Fujinaga, 2018, PLoS pathogens.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014–2015

T. Bedford, L. Ferradini, B. Roche, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon

G. Lachenal, D. Robertson, Felix Feyertag, 2015, PLoS pathogens.

Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02

C. Delaugerre, C. Rouzioux, L. Meyer, 2011, AIDS.

Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir

C. Charpentier, D. Descamps, J. Plantier, 2018, The Journal of antimicrobial chemotherapy.

Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2

R. Apps, F. Kirchhoff, B. Hahn, 2020, mBio.

Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France

C. Charpentier, C. Delaugerre, Felix Feyertag, 2013, AIDS.

Hili Inhibits HIV Replication in Activated T Cells

T. Pan, W. Shao, B. Peterlin, 2017, Journal of Virology.

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

A New Real-Time Quantitative PCR for Diagnosis and Monitoring of HIV-1 Group O Infection

V. Lemée, J. Plantier, M. Gueudin, 2011, Journal of Clinical Microbiology.

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals

C. Charpentier, C. Delaugerre, J. Pawlotsky, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of HIV-1 Group O Genetic Diversity on Genotypic Resistance Interpretation by Algorithms Designed for HIV-1 Group M

C. Charpentier, F. Damond, J. Plantier, 2011, Journal of acquired immune deficiency syndromes.

Baseline Genotypic and Phenotypic Susceptibilities of HIV-1 Group O to Enfuvirtide

C. Charpentier, F. Brun-Vézinet, D. Descamps, 2010, Antimicrobial Agents and Chemotherapy.

Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study)

V. Calvez, C. Charpentier, C. Delaugerre, 2018, The Journal of antimicrobial chemotherapy.

Census and Analysis of Persistent False-Negative Results in Serological Diagnosis of Human Immunodeficiency Virus Type 1 Group O Infections

D. Rousset, C. Henquell, V. Lemée, 2009, Journal of Clinical Microbiology.

HIV-1 group P infection: towards a dead-end infection?

D. Robertson, Felix Feyertag, V. Lemée, 2018, AIDS.

Integrase polymorphism and HIV-1 group O diversity.

P. Roques, B. Roquebert, D. Rousset, 2008, AIDS.

Proceedings of the Frontiers of Retrovirology Conference 2016

Sebastian A. Wagner, R. König, D. Elleder, 2016, Retrovirology.

Raltegravir-based regimens are effective in HIV-1 group O-infected patients.

J. Plantier, V. Daneluzzi, D. Batisse, 2012, Journal of acquired immune deficiency syndromes.

Virological response to integrase strand transfer inhibitor-based antiretroviral combinations in HIV-1 group O-infected patients.

J. Plantier, E. Alessandri-Gradt, G. Unal, 2019, AIDS.

[Specific diagnosis and follow-up of HIV-1 group O infection: RES-O data].

D. Descamps, V. Lemée, F. Damond, 2010, Medecine et maladies infectieuses.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.

Contribution of Antibiotic Susceptibility Testing and CH Typing Compared to Next-Generation Sequencing for the Diagnosis of Recurrent Urinary Tract Infections Due to Genetically Identical Escherichia coli Isolates: a Prospective Cohort Study of Cystitis in Women

F. Caron, M. Pestel-Caron, S. Dahyot, 2023, Microbiology spectrum.